Published in J Neurol Neurosurg Psychiatry on October 01, 1990
Neurological emergencies: acute stroke. J Neurol Neurosurg Psychiatry (2000) 1.62
Influx of leukocytes and platelets in an evolving brain infarct (Wistar rat). Am J Pathol (1994) 1.56
Acute ischaemic stroke. BMJ (2000) 1.52
Primary intracerebral haemorrhage in the Jyväskylä region, central Finland, 1985-89: incidence, case fatality rate, and functional outcome. J Neurol Neurosurg Psychiatry (1992) 1.21
Who needs antiplatelet therapy? Br J Gen Pract (1996) 1.10
Estimating the "avoidable" burden of disease by Disability Adjusted Life Years (DALYs). Health Care Manag Sci (2000) 1.07
Pattern of neurological admissions in the tropics: Experience at Kano, Northwestern Nigeria. Ann Indian Acad Neurol (2010) 1.00
Effect of aspirin and warfarin on early survival after intracerebral haemorrhage. J Neurol (2008) 0.85
Tolerance of a standing tilt table protocol by patients an inpatient stroke unit setting: a pilot study. J Neurol Phys Ther (2013) 0.81
Adiposity and ischemic and hemorrhagic stroke: Prospective study in women and meta-analysis. Neurology (2016) 0.80
Factors associated with death and predictors of one-month mortality from stroke in Kano, Northwestern Nigeria. J Neurosci Rural Pract (2013) 0.79
Effects of thrombolysis for acute stroke in patients with pre-existing disability. CMAJ (2003) 0.79
Stroke in patients with diabetes mellitus: a study from North Western Nigeria. Afr Health Sci (2016) 0.77
Stroke management. BMJ Clin Evid (2011) 0.77
Temporal trends and risk factors for readmission for infections, gastrointestinal and immobility complications after an incident hospitalisation for stroke in Scotland between 1997 and 2005. BMC Neurol (2015) 0.75
Early mobilization in ischemic stroke: a pilot randomized trial of safety and feasibility in a public hospital in Brazil. Cerebrovasc Dis Extra (2015) 0.75
Prophylactic Antibiotic Therapy for Preventing Poststroke Infection. Neurotherapeutics (2016) 0.75
Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J (1957) 8.43
A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project--1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (1990) 5.82
A prospective study of 1152 hospital autopsies: I. Inaccuracies in death certification. J Pathol (1981) 5.61
A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-86. 1. Methodology, demography and incident cases of first-ever stroke. J Neurol Neurosurg Psychiatry (1988) 4.98
Interobserver agreement for the assessment of handicap in stroke patients. Stroke (1989) 4.39
Why are patients with acute stroke admitted to hospital? Br Med J (Clin Res Ed) (1986) 2.96
A prospective study of 1152 hospital autopsies: II. Analysis of inaccuracies in clinical diagnoses and their significance. J Pathol (1981) 2.81
Early mortality following stroke: a prospective review. Stroke (1984) 2.38
An evaluation of risk factors for stroke in a Dutch community. Stroke (1982) 1.79
Incidence rates of stroke in the eighties: the end of the decline in stroke? Stroke (1989) 1.59
Acute stroke management and patient outcome: the value of Neurovascular Care Units (NCU). Stroke (1974) 1.59
Event, incidence and case fatality rates of cerebrovascular disease in Auckland, New Zealand. Am J Epidemiol (1984) 1.51
Swelling of the brain following ischemic infarction with arterial occlusion. Arch Neurol (1959) 1.48
Decreasing trend in incidence and mortality from stroke in Hisayama residents, Japan. Stroke (1981) 1.40
Subarachnoid and intracerebral hemorrhage: natural history, prognosis, and precursive factors in the Framingham Study. Neurology (1984) 1.38
Is a controlled trial of long-term oral anticoagulants in patients with stroke and non-rheumatic atrial fibrillation worthwhile? Lancet (1986) 1.31
The decreasing incidence of primary intracerebral hemorrhage: a population study. Ann Neurol (1979) 1.26
Mid-Missouri stroke survey: a preliminary report. Mo Med (1966) 1.19
Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke. Age Ageing (1986) 1.18
Has there been a decline in subarachnoid hemorrhage mortality? Stroke (1989) 1.11
Mechanisms and timing of deaths from cerebral infarction. Stroke (1982) 1.11
Accuracy of death certification of stroke: the Framingham Study. Stroke (1983) 1.11
Sudden death from stroke. Stroke (1977) 1.00
Mortality factors in patients with acute stroke. JAMA (1973) 0.97
The changing pattern of survival following stroke. Stroke (1984) 0.97
Time course of cerebral swelling in stroke: a correlative autopsy and CT study. Adv Neurol (1980) 0.89
Autopsy-verified causes of death after stroke. Acta Med Scand (1987) 0.88
Necropsies on patients after stroke. Br Med J (Clin Res Ed) (1985) 0.81
Framework for design and evaluation of complex interventions to improve health. BMJ (2000) 28.39
Evaluation of a stroke family care worker: results of a randomised controlled trial. BMJ (1997) 12.99
Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet (1991) 12.30
Molecular analysis of cellulose biosynthesis in Arabidopsis. Science (1998) 7.51
Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J (Clin Res Ed) (1988) 6.76
A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project--1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (1990) 5.82
Using patient-identifiable data for observational research and audit. BMJ (2000) 5.52
A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-86. 1. Methodology, demography and incident cases of first-ever stroke. J Neurol Neurosurg Psychiatry (1988) 4.98
Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet (2007) 4.62
Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc Natl Acad Sci U S A (2000) 4.46
DiGeorge syndrome: part of CATCH 22. J Med Genet (1993) 4.30
Velo-cardio-facial syndrome associated with chromosome 22 deletions encompassing the DiGeorge locus. Lancet (1992) 4.07
Effect of timing and method of enteral tube feeding for dysphagic stroke patients (FOOD): a multicentre randomised controlled trial. Lancet (2005) 3.64
Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet (1997) 3.41
Peutz-Jeghers syndrome: a systematic review and recommendations for management. Gut (2010) 3.22
Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet (2001) 3.15
Prognosis of transient ischemic attacks in the Oxfordshire Community Stroke Project. Stroke (1990) 3.15
Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nat Med (1996) 2.96
Why are patients with acute stroke admitted to hospital? Br Med J (Clin Res Ed) (1986) 2.96
Do medically unexplained symptoms matter? A prospective cohort study of 300 new referrals to neurology outpatient clinics. J Neurol Neurosurg Psychiatry (2000) 2.89
Routine oral nutritional supplementation for stroke patients in hospital (FOOD): a multicentre randomised controlled trial. Lancet (2005) 2.81
Molecular genetic study of the frequency of monosomy 22q11 in DiGeorge syndrome. Am J Hum Genet (1992) 2.70
Value of computed tomography in patients with stroke: Oxfordshire Community Stroke Project. Br Med J (Clin Res Ed) (1985) 2.67
Preferential deletion of exons in Duchenne and Becker muscular dystrophies. Nature (1987) 2.67
Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut (2008) 2.65
X-linked situs abnormalities result from mutations in ZIC3. Nat Genet (1997) 2.62
Hyponatraemia: mechanisms and management. Lancet (1981) 2.55
Neurological disease, emotional disorder, and disability: they are related: a study of 300 consecutive new referrals to a neurology outpatient department. J Neurol Neurosurg Psychiatry (2000) 2.52
Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol (2000) 2.50
The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry (1991) 2.49
A homeobox gene, HLXB9, is the major locus for dominantly inherited sacral agenesis. Nat Genet (1998) 2.48
VACTERL with hydrocephalus: one end of the Fanconi anemia spectrum of anomalies? Am J Med Genet (1992) 2.47
Strategy for stroke. BMJ (1991) 2.43
Deletions within chromosome 22q11 in familial congenital heart disease. Lancet (1992) 2.29
The natural history of lacunar infarction: the Oxfordshire Community Stroke Project. Stroke (1987) 2.24
Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques. Nat Med (1995) 2.23
A prospective cytogenetic study of 36 cases of DiGeorge syndrome. Am J Hum Genet (1992) 2.23
Inverse agonist activity of beta-adrenergic antagonists. Mol Pharmacol (1994) 2.22
Confirmation that the velo-cardio-facial syndrome is associated with haplo-insufficiency of genes at chromosome 22q11. Am J Med Genet (1993) 2.21
Characterization of the supernumerary chromosome in cat eye syndrome. Science (1986) 2.19
European Code Against Cancer and scientific justification: third version (2003). Ann Oncol (2003) 2.17
Projecting the number of patients with first ever strokes and patients newly handicapped by stroke in England and Wales. BMJ (1989) 2.17
Monozygotic twins with chromosome 22q11 deletion and discordant phenotype. J Med Genet (1995) 2.13
TPA within 3 hours of acute ischaemic stroke? Lancet (1996) 2.06
Structure of the high-affinity binding site for noncompetitive blockers of the acetylcholine receptor: serine-262 of the delta subunit is labeled by [3H]chlorpromazine. Proc Natl Acad Sci U S A (1986) 2.06
Hereditary haemorrhagic telangiectasia: a clinical analysis. J Med Genet (1992) 2.05
Brachmann-de Lange syndrome. Delineation of the clinical phenotype. Am J Med Genet (1993) 2.00
Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire Community Stroke Project. Stroke (1994) 2.00
Geographical and secular trends in stroke incidence. Lancet (1987) 1.94
Is the EuroQol a valid measure of health-related quality of life after stroke? Stroke (1997) 1.94
Mood disorders in the year after first stroke. Br J Psychiatry (1991) 1.93
Body mass index and the risk of obesity in coeliac disease treated with the gluten-free diet. Aliment Pharmacol Ther (2012) 1.89
Depression after stroke and lesion location: a systematic review. Lancet (2000) 1.87
A systematic review of the frequency and prognosis of arteriovenous malformations of the brain in adults. Brain (2001) 1.87
Gluten-free diet survey: are Americans with coeliac disease consuming recommended amounts of fibre, iron, calcium and grain foods? J Hum Nutr Diet (2005) 1.81
Motor neuron disease in England and Wales, 1959-1979. J Neurol Neurosurg Psychiatry (1983) 1.81
A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. Nat Genet (2000) 1.80
Isolation and characterization of mutants defective in seed coat mucilage secretory cell development in Arabidopsis. Plant Physiol (2001) 1.77
Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants. J Gen Virol (1994) 1.77
Emotionalism after stroke. BMJ (1989) 1.76
Predicting functional outcome in acute stroke: comparison of a simple six variable model with other predictive systems and informal clinical prediction. J Neurol Neurosurg Psychiatry (2004) 1.72
Williams syndrome. J Med Genet (1986) 1.72
Disability, distress and unemployment in neurology outpatients with symptoms 'unexplained by organic disease'. J Neurol Neurosurg Psychiatry (2011) 1.69
Aspirin for strokes and transient ischaemic attacks. BMJ (1988) 1.68
Smith-Lemli-Opitz syndrome: a variable clinical and biochemical phenotype. J Med Genet (1998) 1.65
A terminal deletion of the long arm of chromosome 4 [46,XX,del(4)(q33)] in an infant with phenotypic features of Williams syndrome. J Med Genet (1986) 1.65
Autosomal dominant sacral agenesis: Currarino syndrome. J Med Genet (2000) 1.64
A female infant with features of Mohr and Majewski syndromes: variable expression, a genetic compound, or a distinct entity? J Med Genet (1983) 1.63
Access to computed tomography in British accident and emergency departments. BMJ (1997) 1.63
Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for msh2 mutations. Genomics (1994) 1.63
Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus. Nat Genet (2000) 1.62
Neurological emergencies: acute stroke. J Neurol Neurosurg Psychiatry (2000) 1.62
Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial. Stroke (2003) 1.60